Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: An unnecessary and insufficiently substantiated precaution

Birth Defects Res A Clin Mol Teratol. 2016 Oct;106(10):860-861. doi: 10.1002/bdra.23556. Epub 2016 Sep 28.

Authors

Per Damkier¹, Anneke Passier², Lotte Bo Petersen¹, Gro Havnen³, Andreas James Thestrup Pedersen¹

Affiliations

¹ Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
² Teratology Information Service Lareb, 's-Hertogenbosch, The Netherlands.
³ Regional Medicines Information and Pharmacovigilance Centre, Oslo University Hospital, Oslo, Norway.

PMID: 27678452
DOI: 10.1002/bdra.23556

No abstract available

Publication types

Letter

MeSH terms

Congenital Abnormalities / prevention & control
Drug Labeling*
Humans
Male
Mycophenolic Acid / adverse effects*
Paternal Exposure / adverse effects*
Teratogens

Substances

Teratogens
Mycophenolic Acid